ClinicalTrials.gg
RecruitingNCT05855928Updated May 12, 2023

Effectiveness of ES and MT VS ES and PNF Technique Among Bells Palsy Patients

An interventional study of Mime Therapy and PNF Technique in Bell Palsy, sponsored by Superior University. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-05-12.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jun 2023, 3 years 5 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

To determine the effectiveness of electrical stimulation with MIME therapy versus electrical stimulation with PNF technique for improving strength \& restoring lost motor function in the patients of Bell's palsy

02

Conditions studied

  • Bell Palsy

Browse trials for

03

In context

Bell Palsy

85 studies on the registry are indexed under Bell Palsy; 30 are open to participants now.

This study's planned enrollment of 56 is above the median of 42 across 70 interventional studies indexed under Bell Palsy.

Browse Bell Palsy studies →

Lead sponsor

Superior University is the lead sponsor of 253 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Acute, unilateral, lower motor neuron bells palsy patient with house-backmann scale 4

      • Acute onset 1-3 weeks
      • Age group 20-40 years
      • Who were are willing to be a part of the study
      • Patients with the Bell's palsy (Facial paralysis , idiopathic facial paralysis and the herpetic facial paralysis)

Exclusion criteria

Exclusion Criteria:

    • Patient who had the disorder, tumors, recent head injury

      • The subject long with the surgery for ear and the fascial nerve palsy
      • Metal dental implants, and pregnant women
      • The patient with any peripheral vascular diseases
      • Central fascial palsy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Other
    Electrical Stimulation and Mime Therapy

    Diagnostic Test: Mime Therapy

  • Experimental
    Electrical Stimulation and PNF Technique

    Diagnostic Test: PNF Technique

Interventions

  • Diagnostic testMime Therapy

    electrical stimulation with the MIME therapy and protocol

  • Diagnostic testPNF Technique

    electrical stimulation with the PNF technique with the routine physical therapy

06

What researchers measure

Primary outcomes

  1. Facial disability index(FDI) Scale

    Physical function, Difficulties

    Time frame: 6 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2023 (actual). Primary completion is estimated for Jun 2023, 2 months after the start.

Of 38 non-industry interventional studies with no phase under Bell Palsy, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 25. This study's planned 2 months is below that.

Counting every sponsor, half of 40 studies reached it within 10 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2023
First posted
May 12, 2023
StartActual
Apr 1, 2023
Primary completionEst.
Jun 1, 2023
CompletionEst.
Aug 31, 2023
Last update
May 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05855928
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
May 12, 2023
Start date
Apr 1, 2023
Primary completion
Jun 1, 2023 (estimated)
Completion
Aug 31, 2023 (estimated)
Last update
May 12, 2023

Study contacts

Javeria khalid, DPT
Contact
javeriakhalid14@gmail.com
+923074464878

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion